Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer
Vincent, Mark D, Breadner, Daniel, Soulieres, Denis, Kerr, Ian G, Sanatani, Michael, Kocha, Walter, Klimo, Peter, MacKenzie, Mary J, O’Connell, Anne, Whiston, Frances, Malpage, Anne S, Stitt, Larry, WVolume:
13
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2016-0444
Date:
April, 2017
File:
PDF, 1.80 MB
english, 2017